Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
62.6M
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
2.7M
-
Shares change
-
-678K
-
Total reported value, excl. options
-
$4.13M
-
Value change
-
-$1.25M
-
Put/Call ratio
-
1
-
Number of buys
-
11
-
Number of sells
-
-28
-
Price
-
$1.53
Significant Holders of Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) as of Q2 2024
53 filings reported holding IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2024.
Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.7M shares
of 62.6M outstanding shares and own 4.31% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (992K shares), GEODE CAPITAL MANAGEMENT, LLC (266K shares), RICE HALL JAMES & ASSOCIATES, LLC (224K shares), Richmond Brothers, Inc. (191K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (164K shares), BlackRock Inc. (107K shares), Knoll Capital Management, LLC (100K shares), STATE STREET CORP (70.5K shares), MORGAN STANLEY (56.1K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (46.6K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.